The role of Malassezia species in the ecology of human skin and as pathogens

Medical Mycology, Supplement

Volumn 36, Issue 1, 1998, Pages 220-229

  Gueho E ^a   Boekhout, T ^b   Ashbee, H R ^c   Guillot, J ^d   Van Belkum, A ^e   Faergemann, J ^f  

^a INSTITUT PASTEUR   (France)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Immunology; Malassezia; Pathogenicity; Taxonomy; Treatment

Indexed keywords

ANTIFUNGAL AGENT; CYTOKINE; ITRACONAZOLE; KETOCONAZOLE; MEMBRANE LIPID;

ATOPIC DERMATITIS; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DERMATOMYCOSIS; FOLLICULITIS; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; MALASSEZIA; MALASSEZIA FURFUR; MALASSEZIA OVALIS; MALASSEZIA PACHYDERMATIS; ORAL DRUG ADMINISTRATION; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SEBORRHEIC DERMATITIS; SPECIES; TAXONOMY; TINEA VERSICOLOR; TOPICAL DRUG ADMINISTRATION; YEAST;

ANTIBODIES, FUNGAL; DERMATOMYCOSES; EPIDEMIOLOGY, MOLECULAR; HUMANS; IMMUNITY, CELLULAR; MALASSEZIA; MYCOLOGICAL TYPING TECHNIQUES; SKIN;

EID: 0032314074     PISSN: 09668454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (83)

1. Slooff WC. Genus 6. Pityrosporum Sabouraud. In: Lodder J, ed. The Yeasts, A Taxonomic Study, 2nd edn. Amsterdam: North-Holland Publ 1970 1167-1186.
2. Baillon H (ed.). Traité de botanique médicale cryptogamiqite. Paris: Octave Doin 1889 234-235.
3. Sabouraud R. Les maladies desquamatives. Maladies du cuir chevelu. Paris: Masson et Cie 1904.
4. Keddie FM. Electron microscopy of Malassezia furfur in tinea versicolor. Sabouraudia 1966; 5: 134-45.
5. Yarrow D, Ahearn DG. Malassezia Baillon. In: Kreger-van RIJ NJW, ed. The Yeasts, A Taxonomic Study, 3rd edn. Amsterdam: Elsevier Sc Publ BV 1984 882-885.
6. Simmons RB, Guého E. A new species of Malasiezia. Mycol Res 1990; 94: 1146-9.
7. Castellani A, Chalmers AJ. (eds) Manual of Tropical Medicine, 2nd edn. London: Baillère, Tindall and Cox 1913 1747.
8. Gordon MA. The lipophilic mycoflora of the skin. 1. In vitro culture of Pityrosporum orbiculare n. sp. Mycologia 1951; 43: 524-35.
9. Weidman FD. Exfoliative dermatitis in the Indian rhinoceros (Rhinoceros unicornis), with description of a new species: Pityrosporum pachydermatis. In: Fox H, ed. Rep Lab Museum Comp Zoo Soc. Philadelphia 1925; 36-45.
10. Guillot J, Chermette R, Guého E. Prévalence du genre Malassezia chez les mammifères. J Mycol Méd 1994; 4: 72-9.
11. Midgley G. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologia 1989; 106: 143-53.
12. Cunningham AC, Leeming JP, Ingham E, Gowland G. Differentiation of three serovars of Malassezia furfur. J Appl Bacteriol 1990; 68: 439-46.
13. Guillot J, Guého E. The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie van Leeuwenhoek 1995; 67: 297-314.
14. Guého E, Faergemann J, Lyman C, Anaissie EJ. Malassezia and Trichosporon, two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol 1994; 32 (Suppl. 1): 367-78.
15. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996; 69: 337-5.
16. Guillot J, Guého E, Lesourd M, Midgley G, Chévrier G, Dupont B. Identification of Malassezia species: a practical approach. J Mycol Méd 1996; 6: 103-10.
17. Mayser P, Haze P, Papavassilis C, Pickel M, Gründer K, Guého E. Differentiation of Malassezia spp. - selectivity of Cremophor EL, castor oil and ricinoleic acid for M. furfur. Br J Dermatol 1997; 137: 208-13.
18. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. The carriage of Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Br J Dermatol 1993; 129: 533-40.
19. Midgley G, Guého E, Guillot J. Malassezia species. In: Hay RJ and Ajello L, eds. Topley & Wilson's Microbiology and Microbial Infections. Superficial keratinophilic fungi, London: Arnold Publ 1997 Vol. 4, Part IV, Chap 12 : 201-11.
20. Guitlot J, Guého E, Chermette R. Confirmation of the nomenclatural status of Malassezia pachydermatis. Antonie van Leeuwenhoek 1995; 67: 173-6.
21. Guillot J, Guého E, Chévrier G, Chermette R. Epidemiological analysis of Malassezia pachydermatis isolates by partial sequencing of the large subunit ribosomal RNA. Res Vet Sci 1997; 62: 22-5.
22. Guého E, Meyer SA. A reevaluation of the genus Malassezia by means of genome comparison. Antonie van Leeuwenhoek 1989; 55: 245-51.
23. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996; 22: s112-s118.
24. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462-78.
25. Schoepfer C, Carla H, Bezou MJ, et al. Malassezia furfur septicemia after bone marrow graft. Arch Pediatr 1995; 2: 245-8.
26. Shaparago NI, Bruno PP, Bennett J. Systemic Malassezia furfur infection in an adult receiving total parenteral nutrition. J Am Osteopath Assoc 1995; 95: 375-7.
27. Akpata LE, Gugnoin HC, Srivastava R, Utsalo SJ. Dermatomycoses among industrial workers in cross River State, Nigeria. Mycoses 1992; 35: 371-4.
28. Dankner WM, Spector SA, Fierer J, Davis CE. Malassezia fungaemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis 1987; 9: 743-53.
29. Surmont I, Gavilenes A, Vandepitte J, Eggermont E. Malassezia furfur fungaemia in infants receiving intravenous lipid emulsions. A rarity or just underestimated? Eur J Pediatr 1989; 148: 435-8.
30. Stuart SM, Lane AT Candida and Malassezia as nursery pathogens. Semin Dermatol 1992; 11: 19-23.
31. Nichols JM, Yuen KY, Saing H. Malassezia furfur infection in a neonate. Br J Hosp Med 1993; 49: 425-7.
32. Boekhout T, Bosboom RW. Karyotyping of Malassezia yeasts: taxonomic and epidemiological implications. Syst Appl Microbiol 1994; 17: 146-53.
33. Silva V, Di Tilia C, Fischman O. Skin colonisation by Malassezia furfur in healthy children up to 15 years old. Mycopathologia 1996; 132: 143-5.
34. Rapelanoro R, Mortureux P, Couprie B, Malleville J, Taieb A Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132: 190-3.
35. Larocco M, Dorenbaum A, Robinson A, Pickering LK. Recovery of Malassezia pachydermatis from eight infants in a neonatal intensive care nursery: clinical and laboratory features. Pediatr Infect Dis J 1988; 7: 398-401.
36. Michelsen PA, Viano-Paulson MC, Stevens DA, Diaz PS. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J Inf Dis 1988; 157: 1163-8.
37. Guého E, Simmons RB, Pruitt WR, Meyer SA, Ahearn DG. Association of Malassezia pachydermatis with systemic infections of humans. J Clin Microbiol 1987; 25: 1789-90.
38. Welbel SF, McNeil MM, Pramanik A, et al. Nosocomial Malassezia pachydermatis blood stream infections in a neonatal intensive care unit. Pediatr Infect Dis J 1994; 13: 104-8.
39. Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev 1992; 5: 101-19.
40. Kiuchi A, Taharaguchi S, Hanazawa R, et al. Chromosome-sized DNA of Malassezia pachydermatis by pulsed-field gel electrophoresis. J Vet Med Sci 1992; 54: 1219-20.
41. Boekhout T, Renting M, Scheffer WA, Bosboom R. The use of karyotyping in the systematics of yeasts. Antonie van Leeuwenhoek 1993; 63: 157-63.
42. Howell SA, Qiun C, Midgley G. Karyotypes of oval cell forms of Malassezia furfur. Mycoses 1993; 36: 263-6.
43. Van Belkum A, Boekhout T, Bosboom R. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J Clin Microbiol 1994; 32: 2528-32.
44. Yoganathan T, Lind H, Buck GA. An electrophoretic karyotype and assignment of ribosomal genes to resolved chromosomes of Pneumocystis carinii. Mol Microbiol 1989; 3: 1473-80.
45. Sohnle PG, Collins-Lech C. Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor. J Clin Invest 1978; 62: 45-53.
46. Sohnle PG, Collins-Lech C. Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor. Clin Exp Immunol 1982; 49: 559-64.
47. Wu C, Chen Kt. Lymphocyte proliferation to crude extract of Pityrosporum species and natural killer activity in tinea versicolor. J Med Assoc Thailand 1985 70 (Suppl. 3): 45.
48. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 106-12.
49. Bergbrant I-M, Johansson S, Robbins D, et al. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331-8.
50. Cunningham AC, Ingham E, Gowland G. Humoral responses to Malassezia furfur serovars A, B and C in normal individuals of various ages. Br J Dermatol 1992; 127: 476-81.
51. Da Mert GJ, Kirkpatrick CH, Sohnle PG. Comparison of antibody responses in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy Appl Immunol 1980; 63: 69-76.
52. wu ye chen Kt. Humoral immunity in patients with tinea versicolor. J Dermatol 1987; 12: 161-6.
53. Furukawa F, Danno K, Imamura S, Soh Y. Histological and serological studies of P. orbiculare in cases of pityriasis versicolor. J Dermatol 1981; 8: 27-30.
54. Ashbee HR, Fruin A, Holland KT, Cunliffe WJ, Ingham E. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 227-33.
55. Midgley G, Hay RJ. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Mycol Méd 1988; 17: 267-76.
56. Bergbrant I-M, Faergemann J. Seborrhoeic dermatitis and Pityrosporum ovale: a cultural and immunological study. Acta Dermatol-Venereol 1989; 69: 332-5.
57. Sohnle PG, Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983; 80: 93-7.
58. Takahashi M, Ushijima T, Ozaki Y. Biological activity of Pityrosporum. I. Enhancement of resistance in mice stimulated by Pityrosporum against Salmonella typhimurium. Immunology 1984; 51: 697-702.
59. Takahashi M, Ushijima T, Ozaki Y. Biological activity of Pityrosporum. II. Antitumour and immune stimulating effect of Pityrosporum in mice. J Nat Cancer Inst 1986; 77: 1093-7.
60. Richardson MD, Shankland GS. Enhanced phagocytosis and intracellular killing of Pityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of the yeast cell surface. Mycoses 1991; 34: 29-33.
61. Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y. Inhibitory effect of azèlaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 1991; 283: 162-6.
62. Stuart AE, Biozzi G, Stiffel C, Halpern BN, Mouton D. The stimulation and depression of reticulo-endothelial phagocytic function by simple lipids. Br J Exp Pathol 1960; 41: 599-604.
63. Spratt MG, Kratzing CC. Oleic acid as a depressant of reticuloendothelial activity in rats and mice J Reticuloendothelial Soc 1975; 17: 135-40.
64. Walters Ce, AshbeeHr Eady Ea. et al. Malassezia furfur suppresses in vitro interleukin-6 release by peripheral blood mononuclear cells. J Invest Dermatol 1995; 105: 492A.
65. Kesavan S, Walters CE, Holland KT, Cunliffe WJ, Ingham E. Malassezia furfur suppresses the release of interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumour necrosis factor-alpha (TNF-α) from human peripheral blood mononuclear phagocytes in vitro. J Invest Dermatol 1996; 107: 447A.
66. Kesavan S, Holland KT, Cunliffe WJ, Ingham E. The effects of de-lipidisation on the immunomodulatory activity of Malassezia species. J Invest Dermatol 1997; 108: 389A.
67. Porro MN, Passi S, Caprill F, et al. Growth requirements and lipid metabolism of Pityrosporum orbiculare. J Invest Dermatol 1976; 66: 178-82.
68. Gordon MA. The lipophilic microflora of the skin. Mycologia 1951; 43: 524-34.
69. Faergemann J, Aly R, Maibach HI. Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Dermatol-Venereol 1983; 63: 346-8.
70. Faergemann J. Pityrosporum infections. In: Elewski BE, ed. Cutaneous Fungal Infections. New York: Igaku-Shoin 1992 69-83.
71. Faergemann J. Tinea versicolor (pityriasis versicolor). In: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven 1995 1-9.
72. Jones HE. Ketoconazole Today. A Review of Clinical Experience. Manchester: ADIS Press 1987.
73. Delescluse J. Itraconazole in tinea versicolor. A review. J Am Acad Dermatol 1990; 23: 551-4.
74. Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Dermatol-Venereol 1992; 72: 74-5.
75. Faergemann J, Djärv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1982; 30: 542-5.
76. Back O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: A common disease of the young and middle-aged. J Am Acad Dermatol 1985; 12: 56-61.
77. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235-42.
78. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: Treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695-700.
79. Bergbrant I-M. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Dermatol-Venereol 1991; 71 (Suppl.): 1-167.
80. Neuber K, Kröger S, Gruseck E, Abeck D, Ring J. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFNγ) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res 1996; 288: 532-6.
81. Kieffer M, Bergbrant I-M, Faergemann J, et al. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrhoeic dermatitis. J Am Acad Dermatol 1990; 22: 739-42.
82. Hjorth N, Clemensen OH. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I hypersensitivity for Pityrosporum orbiculare. Semin Dermatol 1983; 2: 26-9.
83. Kroger S, Neuber K, Gruseck E, Ring J, Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10, and IgE synthesis in patients with atopic eczema. Acta Dermatol-Venereol 1995; 75: 357-60.